Precision Biotics Market Projected to Reach $9.26 billion by 2031 | Top Companies are BioGaia (Sweden) and Novonesis Group (Denmark)

Precision Biotics Market by Type (Precision Probiotics, Next-generation Probiotics, Synbiotics, Postbiotics), End-use Industry, Health/Functional Positioning, Distribution Channel, and Region - Global Forecast to 2031
The precision biotics market [https://www.marketsandmarkets.com/Market-Reports/precision-biotics-market-110337959.html] is projected to grow from USD 4.91 billion in 2026 to reach USD 9.26 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 13.5% during the forecast period. The global precision biotics market is experiencing steady growth. This can be attributed to the increase in the development of microbiome science, along with growing demand for customized health and nutrition products. The increase in awareness regarding the link between the gut microbiome and general health is promoting the use of targeted biotic products. Precision biotics have gained popularity in fields such as digestive health, immune health, metabolic health, cognitive health, and healthy aging due to their scientifically validated, mechanism-based approach.

The market is further driven by factors like the preference of consumers towards products that are scientifically validated, alongside the increase in chronic lifestyle diseases. Companies are investing in activities such as microbiome sequencing, multi-omics, artificial intelligence, and clinical studies to produce more targeted formulations. In addition, collaboration between biotech companies, healthcare organizations, and nutrition firms is boosting innovations in the products. As personalized healthcare continues to evolve and scientific understanding of host microbiome interactions is advancing, precision biotics are expected to become an important component of next-generation nutritional and therapeutic strategies. This will help to support sustained market growth across dietary supplements, functional foods, and medical nutrition applications.

Image: https://mnmimg.marketsandmarkets.com/Images/precision-biotics-market-img-overview.webp

Market Size and Forecast:

* Market Size Value in 2025: USD 4.33 Billion
* Market Size Value in 2026: USD 4.91 Billion
* Revenue Forecast in 2031: USD 9.26 Billion
* Growth Rate: CAGR of 13.5% from 2026 to 2031
* Forecast period: 2026-2031
* North America is estimated to account for the largest share of about 37.6% of the precision biotics market in 2026.
* The precision probiotics segment is estimated to dominate the market with a share of 53.8% in 2026.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=110337959

The next-generation probiotics (NGPs) segment is estimated to be the fastest-growing in the precision biotics market during the forecast period.

The next-generation probiotics (NGPs) segment is expected to be the most rapidly growing category in the precision biotics market because of their ability to offer strain-specific benefits owing to the advancements in the field of microbiomics and clinical trials. More investment in microbiome therapeutics, rising demand for personalized healthcare, and growing use in metabolic, gastrointestinal, immunology, and women's health are driving the acceptance of NGP-based precision biotics.

The cosmetics end-use industry is estimated to be the fastest-growing in the precision biotics market during the forecast period

The cosmetics segment is expected to grow at the fastest pace among the end-user industry segments in the precision biotics market owing to high consumer demand for skincare and beauty products that are skin microbiome-friendly and personalized. Awareness regarding the importance of skin microbiome for skin health maintenance, preference for clean-label science-based cosmetic products, and usage of precision biotics in products meant for the treatment of conditions such as acne, eczema, skin barrier restoration, sensitivity, and anti-aging are some of the factors fueling growth in the market.

The Asia Pacific is the fastest-growing region in the precision biotics market during the forecast period.

The Asia Pacific region is expected to witness the fastest growth in the precision biotics market across the world. Growth in the region is mainly attributed to growing awareness regarding gut health, increasing use of personalized nutrition and preventive healthcare, advances in the area of microbiome studies, and increasing demand for probiotic products that have clinical validation. Growing disposable incomes, increased urbanization, expansion of the dietary supplements industry and functional foods industry, improvements in the healthcare sector, and growing penetration of online retail channels are boosting the adoption of precision biotics.

Leading Precision Biotics Companies [https://www.marketsandmarkets.com/ResearchInsight/precision-biotics.asp]:

The report profiles key players such as BioGaia (Sweden), Novonesis Group (Denmark), Procter & Gamble (US), Unilever (UK), dsm-firmenich (Switzerland), Metagenics, LLC (US), Yakult Honsha Co., Ltd (Japan), Danone (France), KANEKA CORPORATION (Japan), Symrise (Germany)-(Probi), Jarrow Formulas, Inc (US), Pendulum (US), thegoodbug (India), Seed Health, Inc (US), and Infinant Health Inc (US).

Recent Developments in the Precision Biotics Industry [https://www.marketsandmarkets.com/PressReleases/precision-biotics.asp]:

* January 2026: Metagenics acquired UK-based probiotic brand Symprove, expanding its microbiome and gut health portfolio. The acquisition strengthens Metagenics' practitioner-recommended probiotic offerings by adding Symprove's clinically validated water-based probiotic technology, while a strategic debt recapitalization will support future growth and acquisitions.
* June 2025: Danone acquired The Akkermansia Company (TAC), a Belgian biotechnology company specializing in next-generation biotics. The acquisition adds the clinically validated Akkermansia muciniphila MucT strain to Danone's portfolio, strengthening its capabilities in gut health, metabolic health, and precision nutrition as part of its Renew strategy.

About MarketsandMarkets Trademark

MarketsandMarkets Trademark has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets Trademark is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore Trademark , which integrates research and provides ecosystem-wide visibility into revenue shifts.

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=precision-biotics-market-projected-to-reach-926-billion-by-2031-top-companies-are-biogaia-sweden-and-novonesis-group-denmark]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/precision-biotics-market-110337959.html

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.